| GTO ID | GTC1032 |
| Trial ID | ChiCTR-OIB-17013670 |
| Disease | B-Cell Acute Lymphocytic Leukemia |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Phase I study of sequential chimeric antigen receptor T cell therapy targeting at different B-cell antigens in primary refractory or chemotherapeutic relapsed B-cell acute lymphoblastic leukemia |
| Year | 2017 |
| Country | China |
| Company sponsor | Beijing Boren Hospita |
| Cohort 1 | |||||||
|
|||||||